SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]

<p>Abstract</p> <p>Background</p> <p>Oral anticoagulation monitoring has traditionally taken place in secondary care because of the need for a laboratory blood test, the international normalised ratio (INR). The development of reliable near patient testing (NPT) systems...

Full description

Bibliographic Details
Main Authors: Murray Ellen T, Fitzmaurice David A, McCahon Deborah, Fuller Christopher J, Hobbs Richard FD, Allan Teresa F, Raftery James P
Format: Article
Language:English
Published: BMC 2003-09-01
Series:BMC Family Practice
Online Access:http://www.biomedcentral.com/1471-2296/4/11
id doaj-5b26bcccec2a4ef19e2b09a8364af4b1
record_format Article
spelling doaj-5b26bcccec2a4ef19e2b09a8364af4b12020-11-25T03:13:15ZengBMCBMC Family Practice1471-22962003-09-01411110.1186/1471-2296-4-11SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]Murray Ellen TFitzmaurice David AMcCahon DeborahFuller Christopher JHobbs Richard FDAllan Teresa FRaftery James P<p>Abstract</p> <p>Background</p> <p>Oral anticoagulation monitoring has traditionally taken place in secondary care because of the need for a laboratory blood test, the international normalised ratio (INR). The development of reliable near patient testing (NPT) systems for INR estimation has facilitated devolution of testing to primary care. Patient self-management is a logical progression from the primary care model. This study will be the first to randomise non-selected patients in primary care, to either self-management or standard care.</p> <p>Method</p> <p>The study was a multi-centred randomised controlled trial with patients from 49 general practices recruited. Those suitable for inclusion were aged 18 or over, with a long term indication for oral anticoagulation, who had taken warfarin for at least six months. Patients randomised to the intervention arm attended at least two training sessions which were practice-based, 1 week apart. Each patient was assessed on their capability to undertake self management. If considered capable, they were given a near patient INR testing monitor, test strips and quality control material for home testing. Patients managed their own anticoagulation for a period of 12 months and performed their INR test every 2 weeks. Control patients continued with their pre-study care either attending hospital or practice based anticoagulant clinics.</p> <p>Discussion</p> <p>The methodology used in this trial will overcome concerns from previous trials of selection bias and relevance to the UK health service. The study will give a clearer understanding of the benefits of self-management in terms of clinical and cost effectiveness and patient preference.</p> http://www.biomedcentral.com/1471-2296/4/11
collection DOAJ
language English
format Article
sources DOAJ
author Murray Ellen T
Fitzmaurice David A
McCahon Deborah
Fuller Christopher J
Hobbs Richard FD
Allan Teresa F
Raftery James P
spellingShingle Murray Ellen T
Fitzmaurice David A
McCahon Deborah
Fuller Christopher J
Hobbs Richard FD
Allan Teresa F
Raftery James P
SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
BMC Family Practice
author_facet Murray Ellen T
Fitzmaurice David A
McCahon Deborah
Fuller Christopher J
Hobbs Richard FD
Allan Teresa F
Raftery James P
author_sort Murray Ellen T
title SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
title_short SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
title_full SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
title_fullStr SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
title_full_unstemmed SMART: Self-Management of Anticoagulation, a Randomised Trial [ISRCTN19313375]
title_sort smart: self-management of anticoagulation, a randomised trial [isrctn19313375]
publisher BMC
series BMC Family Practice
issn 1471-2296
publishDate 2003-09-01
description <p>Abstract</p> <p>Background</p> <p>Oral anticoagulation monitoring has traditionally taken place in secondary care because of the need for a laboratory blood test, the international normalised ratio (INR). The development of reliable near patient testing (NPT) systems for INR estimation has facilitated devolution of testing to primary care. Patient self-management is a logical progression from the primary care model. This study will be the first to randomise non-selected patients in primary care, to either self-management or standard care.</p> <p>Method</p> <p>The study was a multi-centred randomised controlled trial with patients from 49 general practices recruited. Those suitable for inclusion were aged 18 or over, with a long term indication for oral anticoagulation, who had taken warfarin for at least six months. Patients randomised to the intervention arm attended at least two training sessions which were practice-based, 1 week apart. Each patient was assessed on their capability to undertake self management. If considered capable, they were given a near patient INR testing monitor, test strips and quality control material for home testing. Patients managed their own anticoagulation for a period of 12 months and performed their INR test every 2 weeks. Control patients continued with their pre-study care either attending hospital or practice based anticoagulant clinics.</p> <p>Discussion</p> <p>The methodology used in this trial will overcome concerns from previous trials of selection bias and relevance to the UK health service. The study will give a clearer understanding of the benefits of self-management in terms of clinical and cost effectiveness and patient preference.</p>
url http://www.biomedcentral.com/1471-2296/4/11
work_keys_str_mv AT murrayellent smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
AT fitzmauricedavida smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
AT mccahondeborah smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
AT fullerchristopherj smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
AT hobbsrichardfd smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
AT allanteresaf smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
AT rafteryjamesp smartselfmanagementofanticoagulationarandomisedtrialisrctn19313375
_version_ 1724647891552698368